FDA's 510(k) pathway is getting stronger, medtech attorney says

06/5/2013 | MassDevice.com (Boston)

While the FDA's 510(k) program could be improved, it remains a robust framework for reviewing less-risky devices, medtech attorney Jeffrey Shapiro wrote in an analysis. While Shapiro believes the program could be improved with greater transparency, among other fixes, he does not agree with the Institute of Medicine's 2011 report recommending that the program be scrapped. "[T]he 510(k) program has proven adaptable to a wide variety of devices, and has allowed meaningful premarket review while fostering robust technological innovation," he wrote.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL